January 2020, Episode 44: Dr. Timothy Smith and Dr. Lindsay Weitzel compare and contrast three oral gepants, an IV monoclonal antibody, two combination therapies, and an anti-inflammatory agent – all expected to be available for the treatment of migraine in 2020-2021.
